cognitive cybersecurity intelligence

News and Analysis

Search

New patent for Clarus drug JATENZO

New patent for Clarus drug JATENZO    June 4, 2022    Comments Off on New patent for Clarus drug JATENZO    Posted in: General BiotechnologyAnnual Drug Patent Expirations for JATENZO Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There…

Source: www.biotechblog.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts